Stoke Therapeutics, Inc.
STOK · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Ticho Barry: Form 4
Insider disclosure · Filed · Report period 02 Nov 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- STOK · 86150R107 - COMMON STOCK
Company details and SEC sources
CIK 0001623526 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- STOK on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 45 Wiggins Avenue, Bedford, MA, 01730
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- ASOthera Pharmaceuticals, Inc. (to 24 Nov 2014)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields